Matteo Pardini
Overview
Explore the profile of Matteo Pardini including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
170
Citations
2095
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Caneva S, Hamedani M, Pesaresi A, Mori L, Marzi A, Pellegrino L, et al.
Eur J Neurol
. 2025 Mar;
32(3):e16567.
PMID: 40087849
Background: Idiopathic normal pressure hydrocephalus (iNPH) is a multifactorial progressive disease affecting cognition, gait, and urinary continence, potentially reversible, or at least improvable, by a prompt surgical intervention. Given its...
2.
Losa M, Garbarino S, Cirone A, Argenti L, Lombardo L, Calizzano F, et al.
Cortex
. 2025 Feb;
185:84-95.
PMID: 39999654
Aim: Frontotemporal dementia (FTD) is a heterogeneous neurodegenerative disorder, with considerable variability of age-at-onset. We explored clinical and metabolic differences between early- and late-onset behavioural FTD (bvFTD), assuming that they...
3.
Babiloni C, Arakaki X, Baez S, Barry R, Benussi A, Blinowska K, et al.
Clin Neurophysiol
. 2025 Feb;
172:33-50.
PMID: 39978053
In this "centenary" paper, an expert panel revisited Hans Berger's groundbreaking discovery of human restingstate electroencephalographic (rsEEG) alpha rhythms (8-12 Hz) in 1924, his foresight of substantial clinical applications in...
4.
Plantone D, Pardini M, Manco C, Righi D, Ali P, Arnaldi D, et al.
Ther Adv Neurol Disord
. 2025 Feb;
18:17562864251314773.
PMID: 39974169
Background: Despite their potential usefulness as biomarkers, no study has investigated the interactions between cerebrospinal fluid (CSF) changes of neurofilament light chain (NfL), glial fibrillary acidic protein (GFAP), growth differentiation...
5.
Salamone E, Carpi M, Noce G, Percio C, Lopez S, Lizio R, et al.
Clin Neurophysiol
. 2025 Feb;
171:164-181.
PMID: 39914158
Objectives: Alzheimer's disease patients with mild cognitive impairment (ADMCI) show abnormal resting-state eyes-closed electroencephalographic (rsEEG) alpha rhythms (8-12 Hz) and may suffer from daytime sleepiness. Our exploratory study tested the...
6.
Kiersnowski O, Mattioli P, Argenti L, Avanzino L, Calizzano F, Diociasi A, et al.
Sci Rep
. 2025 Feb;
15(1):4186.
PMID: 39905067
Nigrostriatal dopaminergic degeneration in alpha-synucleinopathies is indirectly reflected by low dopamine transporter (DaT) uptake through [123I]FP-CIT-SPECT. Bulk magnetic susceptibility (χ) in the substantia nigra, from MRI-based quantitative susceptibility mapping (QSM),...
7.
Percio C, Lizio R, Lopez S, Noce G, Jakhar D, Carpi M, et al.
Neurobiol Dis
. 2025 Jan;
206:106807.
PMID: 39855475
Parkinson's disease with dementia (PDD) and dementia with Lewy bodies (DLB) are more prevalent in males than females. Furthermore, they typically showed abnormally high delta (< 4 Hz) and low...
8.
Wiels W, Oomens J, Engelborghs S, Baeken C, von Arnim C, Boada M, et al.
JAMA Psychiatry
. 2025 Jan;
82(3):296-310.
PMID: 39841452
Importance: Depressive symptoms are associated with cognitive decline in older individuals. Uncertainty about underlying mechanisms hampers diagnostic and therapeutic efforts. This large-scale study aimed to elucidate the association between depressive...
9.
Percio C, Lizio R, Lopez S, Noce G, Carpi M, Jakhar D, et al.
Int J Mol Sci
. 2025 Jan;
26(1.
PMID: 39796211
Patients with mild cognitive impairment due to Alzheimer's disease (ADMCI) typically show abnormally high delta (<4 Hz) and low alpha (8-12 Hz) rhythms measured from resting-state eyes-closed electroencephalographic (rsEEG) activity....
10.
Garbarino S, Tur C, Lorenzi M, Pardini M, Piana M, Uccelli A, et al.
Brain Commun
. 2025 Jan;
7(1):fcae434.
PMID: 39777254
This study applies the Gaussian process progression model, a Bayesian data-driven disease progression model, to analyse the evolution of primary progressive multiple sclerosis. Utilizing data from 1521 primary progressive multiple...